99 related articles for article (PubMed ID: 8808182)
1. The use of chromogranin, synaptophysin and islet amyloid polypeptide as markers for neuroendocrine tumours.
Stridsberg M
Ups J Med Sci; 1995; 100(3):169-99. PubMed ID: 8808182
[No Abstract] [Full Text] [Related]
2. Measurements of chromogranin A, chromogranin B (secretogranin I), chromogranin C (secretogranin II) and pancreastatin in plasma and urine from patients with carcinoid tumours and endocrine pancreatic tumours.
Stridsberg M; Oberg K; Li Q; Engström U; Lundqvist G
J Endocrinol; 1995 Jan; 144(1):49-59. PubMed ID: 7891024
[TBL] [Abstract][Full Text] [Related]
3. Fragments of chromogranin A are present in the urine of patients with carcinoid tumours: development of a specific radioimmunoassay for chromogranin A and its fragments.
Stridsberg M; Hellman U; Wilander E; Lundqvist G; Hellsing K; Oberg K
J Endocrinol; 1993 Nov; 139(2):329-37. PubMed ID: 8308469
[TBL] [Abstract][Full Text] [Related]
4. A polyclonal antiserum against chromogranin A and B--a new sensitive marker for neuroendocrine tumours.
Eriksson B; Arnberg H; Oberg K; Hellman U; Lundqvist G; Wernstedt C; Wilander E
Acta Endocrinol (Copenh); 1990 Feb; 122(2):145-55. PubMed ID: 2316306
[TBL] [Abstract][Full Text] [Related]
5. Peptide hormones as tumor markers in neuroendocrine gastrointestinal tumors.
Eriksson B; Oberg K
Acta Oncol; 1991; 30(4):477-83. PubMed ID: 1854505
[TBL] [Abstract][Full Text] [Related]
6. Islet amyloid polypeptide (IAPP) in patients with neuroendocrine tumours.
Stridsberg M; Eriksson B; Lundqvist G; Skogseid B; Wilander E; Oberg K
Regul Pept; 1995 Jan; 55(2):119-31. PubMed ID: 7754100
[TBL] [Abstract][Full Text] [Related]
7. Usefulness of chromogranin A as a marker for detection of relapses of carcinoid tumours.
Pirker RA; Pont J; Pöhnl R; Schütz W; Griesmacher A; Müller MM
Clin Chem Lab Med; 1998 Nov; 36(11):837-40. PubMed ID: 9877088
[TBL] [Abstract][Full Text] [Related]
8. [Synaptophysin, chromogranin A and neuron-specific enolase as tumor markers in neuroendocrine tumors of the gastrointestinal tract and lung. An immunohistochemical study].
Eberlein-Gonska M; Wiedenmann B; Waldherr R
Pathologe; 1989 Jul; 10(4):228-33. PubMed ID: 2549534
[No Abstract] [Full Text] [Related]
9. Recombinant interferon alpha-2b in patients with metastatic apudomas: effect on tumours and tumour markers.
Biesma B; Willemse PH; Mulder NH; Verschueren RC; Kema IP; de Bruijn HW; Postmus PE; Sleijfer DT; de Vries EG
Br J Cancer; 1992 Nov; 66(5):850-5. PubMed ID: 1384643
[TBL] [Abstract][Full Text] [Related]
10. The importance of the measurement of circulating markers in patients with neuroendocrine tumours of the pancreas and gut.
Ardill JE; Erikkson B
Endocr Relat Cancer; 2003 Dec; 10(4):459-62. PubMed ID: 14713258
[TBL] [Abstract][Full Text] [Related]
11. Comparison of chromogranin A and pancreastatin levels in plasma of patients with pancreatic islet cell tumor.
Tateishi K; Kitayama N; Matsuoka Y; Funakoshi A
Life Sci; 1995; 57(9):889-95. PubMed ID: 7630318
[TBL] [Abstract][Full Text] [Related]
12. Chromogranins--new sensitive markers for neuroendocrine tumors.
Eriksson B; Arnberg H; Oberg K; Hellman U; Lundqvist G; Wernstedt C; Wilander E
Acta Oncol; 1989; 28(3):325-9. PubMed ID: 2545231
[TBL] [Abstract][Full Text] [Related]
13. Neuron-specific enolase and chromogranin A as markers of neuroendocrine tumours.
Baudin E; Gigliotti A; Ducreux M; Ropers J; Comoy E; Sabourin JC; Bidart JM; Cailleux AF; Bonacci R; Ruffié P; Schlumberger M
Br J Cancer; 1998 Oct; 78(8):1102-7. PubMed ID: 9792158
[TBL] [Abstract][Full Text] [Related]
14. Plasma islet amyloid polypeptide is not an effective tumor marker for pancreatic cancer even when protease inhibitors and rapid freezing of specimens are utilized.
Tateishi K; DiMagno EP; Klee GG
Clin Chem; 2001 Nov; 47(11):2071-3. PubMed ID: 11673391
[No Abstract] [Full Text] [Related]
15. Effects of sandostatin on plasma chromogranin-A levels in neuroendocrine tumors.
Moattari AR; Deftos LJ; Vinik AI
J Clin Endocrinol Metab; 1989 Oct; 69(4):902-5. PubMed ID: 2778040
[TBL] [Abstract][Full Text] [Related]
16. A panel of 13 region-specific radioimmunoassays for measurements of human chromogranin B.
Stridsberg M; Eriksson B; Oberg K; Janson ET
Regul Pept; 2005 Feb; 125(1-3):193-9. PubMed ID: 15582732
[TBL] [Abstract][Full Text] [Related]
17. Chromogranin A plasma concentration and expression in pancreatic islet cell tumors of dogs and cats.
Myers NC; Andrews GA; Chard-Bergstrom C
Am J Vet Res; 1997 Jun; 58(6):615-20. PubMed ID: 9185968
[TBL] [Abstract][Full Text] [Related]
18. Validation of serum versus plasma measurements of chromogranin a levels in patients with carcinoid tumors: lack of correlation between absolute chromogranin a levels and symptom frequency.
Woltering EA; Hilton RS; Zolfoghary CM; Thomson J; Zietz S; Go VL; Vinik AI; Vinik E; O'Dorisio TM; Mamikunian G
Pancreas; 2006 Oct; 33(3):250-4. PubMed ID: 17003646
[TBL] [Abstract][Full Text] [Related]
19. Isolation, maintenance, and characterization of human pancreatic islet tumor cells expressing vasoactive intestinal peptide.
Tillotson LG; Lodestro C; Höcker M; Wiedenmann B; Newcomer CE; Reid LM
Pancreas; 2001 Jan; 22(1):91-8. PubMed ID: 11138979
[TBL] [Abstract][Full Text] [Related]
20. A comparison of synaptophysin, chromogranin, and L-dopa decarboxylase as markers for neuroendocrine differentiation in lung cancer cell lines.
Jensen SM; Gazdar AF; Cuttitta F; Russell EK; Linnoila RI
Cancer Res; 1990 Sep; 50(18):6068-74. PubMed ID: 2168288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]